FDA Grants Approval for Voriconazole Generic by Zhejiang Novus
The FDA has granted approval for the generic version of Voriconazole under application ANDA220078, submitted by Zhejiang Novus.
Asset / Drug
Drug and asset intelligence for Voriconazole with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.